Health Canada Warns Against Unauthorized Peptides After Bacteria Found in Seized Products
Health Canada is warning consumers not to use certain unauthorized peptide products after laboratory testing identified bacteria in an injectable peptide product seized from an Ottawa retailer. The agency said the contaminated product was among several unauthorized peptide products being sold for human use.
According to Health Canada, laboratory testing identified Sphingomonas aquatilis/melonis bacteria in an injectable peptide product. The agency warned that contaminated injectable products can cause serious infections, hospitalization and potentially life-threatening complications. Following the agency’s enforcement action, the retailer agreed to stop selling the products.
Health Canada said the products included peptides marketed as BPC-157, TB-500, retatrutide, MOTS-C, tesamorelin, SEMAX and MELANOTAN-1. Some products were labeled “For Research Purposes Only.” Health Canada said that designation does not make a product legal for human use and does not exempt it from Canada’s drug regulations.
The warning comes as Canadian regulators increase scrutiny of peptides. In October, Health Canada launched a dedicated peptide information page and stated that it has seen growing numbers of complaints involving unauthorized peptide products sold online and through wellness businesses. The agency notes that many peptides are marketed for anti-aging, weight loss, injury recovery, athletic performance and wellness purposes despite lacking authorization for sale in Canada.
According to Health Canada, peptide drugs intended for human use generally require authorization before they can be marketed in Canada. The agency says authorized products are reviewed for safety, efficacy and quality, while unauthorized products may contain incorrect dosages, undisclosed ingredients or contaminants. Health Canada advises consumers not to purchase peptide products from unauthorized sources and to consult a licensed health care professional regarding treatment options.
